In this pilot episode of Inpatient Update, your host, Dr. Mason Turner, breaks down three clinically relevant studies that could change how you practice tomorrow on the wards:

1. Pre-ERCP antibiotic prophylaxis — does it reduce post-procedure infections in biliary obstruction?
2. Reduced-dose apixaban after 6 months in cancer-associated VTE — noninferior and potentially safer?
3. Early initiation of beta-blockers in cirrhosis with uncomplicated ascites — early signals of benefit.

Practical take-homes, clear links to evidence, and what to tell your team on rounds.

Articles & PubMed Links

1. Is Antibiotic Prophylaxis Warranted in All Patients With Biliary Obstruction Undergoing Endoscopic Retrograde Cholangiopancreatography?: A Systematic Review and Meta-Analysis
   PubMed: https://pubmed.ncbi.nlm.nih.gov/40961256/ 
2. Extended Reduced-Dose Apixaban for Cancer-Associated VTE (API-CAT)
   PubMed: https://pubmed.ncbi.nlm.nih.gov/40162636/ 
3. Efficacy and Safety of Carvedilol in Cirrhosis Patients With New-Onset Uncomplicated Ascites Without High-Risk Esophageal Varices (CARVE-AS Trial)
   PubMed: https://pubmed.ncbi.nlm.nih.gov/40689908/ 

Support the show

Want the cited articles and key takeaways? Join the email list:
https://subscribe.inpatientupdate.com/